2024 International Congress » Parkinson's Disease and Lewy Body Dementia

Meeting: 2024 International Congress

18F-Florzolotau PET uncovers the Co-pathological Heterogeneity of Tau Protein in Dementia with Lewy Bodies

G. Tang, XY. Li, FT. Liu, J. Wang (Shanghai, China)

A Case of Concurrent Wilson Disease and Parkinson Disease

C. Tapia, M. Davis, M. Penon-Portmann, S. Hahn, E. Rezvanian (Seattle, USA)

A case of progressive supranuclear palsy followed by dementia with Lewy bodies

S. Fujita, H. Kawasaki, R. Yokoyama, Y. Ito, T. Yamamoto (Muroyama-cho, Japan)

A Machine Learning Approach for Early Identification of Prodromal Parkinson’s Disease

A. Vaish (Redmond, USA)

Accuracy of Clinical features for Substantia Nigra Hypopigmentation and Cortical Lewy Body Presence in the Oldest-Old: The 90+ Study

R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

Age-associated presbyvestibulopathy is more severely abnormal in PD compared to the older controls

N. Bohnen, G. Carli, T. Brown, S. David, J. Barr, R. Vangel, T. Johnson, K. Kerber, D. Mccaslin (Ann Arbor, USA)

AI for Personalized Medication Management in Parkinson’s Disease

R. Diaz-Rincon, H. Khoshbouei, B. Shickel (Gainesville, USA)

Assessing the Accuracy of Clinical Diagnostic Criteria of Lewy Body Dementia for Detection of Lewy Body Disease in the Oldest-Old: The 90+ Study

R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

Association Between DPP-4 Inhibitors Use and Risk of Dementia: A Meta-analysis Using Real-world Data

S. Hussain (New Delhi, India)

Association between environmental phthalates exposure and gut microbiota and metabolome in dementia with Lewy bodies

J. Zou, Z. Deng, L. Li, J. Jing, X. Luo, F. Yu, W. Zeng, W. Bi (Guangzhou, China)

Association between Kinetic Parameters of Alpha-synuclein Seed Amplification Assay in CSF and Parkinson’s Disease Subtypes.

P. Grillo, G. Riboldi, A. Pisani, L. Concha, U. Kang (New York City, USA)

Association between use of Furosemide and Risk of Parkinson’s disease

B. Babar, AM. Tolppanen, S. Hartikainen, M. Tiihonen (Kuopio, Finland)

Association of β-Amyloid Load on PET with Cognitive Profiles Across the Lewy Body Diseases Continuum

KA. Woo, EJ. Yoon, SY. Kim, HJ. Kim, BR. Jin, SM. Lee, HW. Nam, HW. Park, YK. Kim, JY. Lee (Seoul, Republic of Korea)

Baseline and Longitudinal NSD-ISS Staging of the PPMI Cohort

M. Brumm, T. Simuni, C. Gochanour, L. Chahine, K. Poston, S. Chowdhury, C. Coffey, T. Dam, P. Dibiaso, T. Foroud, M. Fraiser, K. Kieburtz, C. Kopil, K. Merchant, B. Mollenhauer, G. Pagano, J. Seibyl, T. Sherer, D. Stephenson, C. Tanner, E. Tolosa, D. Weintraub, Y. Xiao, A. Siderowf, B. Dunn, K. Marek (Iowa City, USA)

Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson’s Disease

L. Collins-Praino, A. Mcnamara, B. Ellul, I. Baetu, S. Lau, M. Jenkinson (Adelaide, Australia)

Cardiovascular Associations of Cortical Lewy Bodies in the Oldest Old: The 90+ study

R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

Cholinergic Brain Signature of Presbyvestibulopathy in Parkinson’s Disease: Exploring Central Nervous System Vestibular Mechanisms

P. Kanel, G. Carli, T. Brown, S. David, R. Vangel, C. Pongmala, D. Mccaslin, K. Kerber, N. Bohnen (Ann Arbor, USA)

Clinical Profile of Motor Complications in Parkinson’s Disease Patients at A National Tertiary Hospital In Indonesia

Y. Rapri, A. Jody, A. Tiksnadi, D. Tunjungsari (Depok, Indonesia)

Concordance of Neuropathologic Diagnosis of Lewy Body Disease with Baseline Alpha-Synuclein Seed Amplification Assay in PPMI

K. Poston, J. Ha, T. Montine, S. Bukhari, T. Foroud, L. Heathers, K. Nudelman, I. Aldecoa, A. Garrido, J. Franz, C. Stadelmann, J-P. Vonsattel, A. Siderowf, L. Chahine, T. Simuni, K. Marek (Stanford, USA)

CSF Neurogranin Levels Are Decreased in Parkinson Disease

H. Hwang, R. Miller, T. Cash, A. Eid, E. Herries, R. White Iii, B. Maiti, S. Schindler, J. Jackson, J. Perlmutter, M. Campbell, P. Kotzbauer (SAINT LOUIS, USA)

Diffusion MRI and Machine Learning Distinguish Alzheimer’s Disease and Dementia with Lewy Bodies

R. Chen, W. Wang, A. Barmpoutis, D. Vaillancourt (Gainesville, USA)

Early Dementia with Lewy Bodies and Parkinson’s Disease with RBD: two faces of the same coin?

B. Orso, P. Mattioli, F. Famà, F. Massa, M. Pardini, A. Brugnolo, N. Girtler, S. Raffa, L. Sofia, S. Morbelli, D. Arnaldi (Genoa, Italy)

EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases.

R. Heo, J. Wallner, N. Mukhopadhyay, D. Krusienski, M. Barrett (Richmond, USA)

Establishing α-Synuclein Seeding Activity in Saliva as a Noninvasive Diagnostic Biomarker for Parkinson’s Disease

Z. Wang, S. Gunzler, S. Chen, Q. Kong (Cleveland, USA)

Exploring Vestibulopathy in PD: Distinguishing PD from Age-related Presbyvestibulopathy via Dynamic Gait and Balance Assessment

G. Carli, D. Mccaslin, T. Brown, S. David, J. Barr, R. Vangel, A. Luker, C. Pongmala, K. Kerber, N. Bohnen (Ann Arbor, USA)

Focused Ultrasound Therapy Treatment for Parkinson’s Disease

Z. Muttalib, B. Syed, M. Alam, D. Nadora, U. Ansari, R. Sedighi, A. Vemulapalli, S. Asad (Elk Grove, USA)

Free-water MRI Correlates of Pareidolia in Dementia with Lewy Bodies

S. Chiu, R. Chen, W. Wang, G. Smith, B. Boeve, R. Savica, V. Ramanan, J. Fields, N. Graff-Radford, T. Ferman, K. Kantarci, J. Leverenz, N. Armstrong, D. Vaillancourt (Scottsdale, USA)

Identification of Novel Blood Biomarkers among Data-Driven Parkinson’s Disease Clusters in Asian Populations

X. Dneg, L. Tan, E. Tan, A. Ng, J. Tan (Singapore, Singapore)

Impact of Prior Head Trauma on Parkinson’s Disease Experience

S. Vallamkonda, A. Hohler (Boston, USA)

Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites

S. Vallamkonda, D. Petrosyan, B. Westbrook, N. Kakos, C. Hinds, R. Adlis, A. Menta, J. Lowry, D. Brooks, O. Hofheinz, P. Bhaya, J. Kong, M. Muppirala, A. Benchouia, A. Fajayan, A. Hohler, E. Vaou (Boston, USA)

Increased cholinergic activity in specific brain regions associated with the presence of dyskinesias in Parkinson’s disease: A [18F]-FEOBV PET study

N. Bohnen, G. Carli, F. Michalakis, C. Pongmala, M. Emde Boas, R. Albin, P. Kanel (Ann Arbor, USA)

MDS Clinical Supportive Criteria for Parkinson’s Disease are Associated with α-Synuclein Seed Amplification Assay Status

D. Belete, E. Mitchell, N. Donkor, A. Noyce, C. Simonet (London, United Kingdom)

Mild Behavioral Impairment in Lewy body disease: a potential marker of phenoconversion and disease severity

B. Jin, E. Yoon, S. Kim, S. Lee, H. Nam, Y. Kim, B. Jeon, J. Lee (Seoul, Republic of Korea)

New α-Synuclein Strain Biomarker in Parkinson’s Disease and Related Dementia

K. Gadhave, R. Chen, V. Dawson, T. Dawson, L. Rosenthal, X. Mao ()

Oral health in Parkinson’s disease patients from countries with different economies: preliminary results of the OralPark study.

S. Rota, L. Batzu, A. Biondi, I. Boura, D. Urso, S. Diaconu, Y. Lau, I. Inês, P. Tall, P. Lyra, S. Puspasari, S. Gilani, P. Zinzalias, L. Neumaier, P. Pablo, C. Santoro, S. Landolfo, K. Popławska-Domaszewicz, C. Spanaki, P. Odin, DK. Sreenivas, LK. Prashanth, C. Falup-Pecurariu, A. Rizos, J. Botelho, KR. Chaudhuri (UK, United Kingdom)

Parkinson’s disease in a Special Population -Diagnosis and treatment of Parkinson’s disease in cases of psychiatric disorders treated with dopamine receptors antagonists-

M. Nomoto, S. Oda, H. Doi (Imabari, Japan)

Passive smartphone speech monitoring in isolated rapid eye movement sleep behaviour disorder

V. Illner, M. Novotny, T. Kouba, T. Tykalova, M. Simek, P. Sovka, J. Svihlik, E. Ruzicka, K. Sonka, P. Dusek, J. Rusz (Prague 6, Czech Republic)

Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update

T. Simuni, C. Coffey, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, B. Saville, C. Allen-Savietta, B. Wendelberger, A. Crawford, K. Fabrizio, K. Marek (Chicago, USA)

Plasma Biomarkers of Alzheimer’s Pathology Identify Prodromal Dementia with Lewy bodies

A. Delva, A. Pelletier, E. Sommerville, J. Montplaisir, J. Gagnon, G. Kollmorgen, T. Kam-Thong, T. Kustermann, V. Machado, Z. Gan-Or, R. Postuma (Montreal, Canada)

Plasma pTau181 and pTau217 Detect Amyloid Co-pathology and Have Specific Cut-offs in Lewy Body Disease

A. Smith, M. Plastini, N. Ashton, L. Montoliu-Gaya, E. Wilson, B. Arslan, C. Young, J. Winer, M. Shahid-Besanti, H. Vossler, G. Kerchner, B. Cholerton, K. Andreasson, M. Yutsis, V. Henderson, T. Montine, L. Tian, E. Mormino, H. Zetterberg, K. Poston, C. Abdelnour (Stanford, USA)

Prediction of amyloid positivity in Dementia with Lewy bodies using the early-phase 18F-FP-CIT PET images

SJ. Chung, SH. Kim, PH. Lee, YH. Sohn, Y. Jeong, YJ. Kim (Yongin-si, Republic of Korea)

Prediction of Time-to-Phenoconversion to Parkinsonism in Idiopathic REM Sleep Behavior Disorder (iRBD)

SM. Fereshtehnejad, A. Delva, Y. Zeighami, M. Dadar, A. Pelletier, J. Montplaisir, JF. Gagnon, C. Marras, R. Postuma (Toronto, Canada)

Preventing Treatment Disruptions: The Crucial Role of Outpatient Nurses and Multidisciplinary Collaboration in Managing Skin Complications during Foslevodopa/Foscarbidopa Therapy

T. Kojiri, N. Nishikawa, Y. Uchida, M. Nozaki, N. Yoshihara, S. Ueno, G. Oyama, T. Hatano, N. Hattori (Tokyo, Japan)

Progression of motor asymmetry in the MDS-UPDRS III in Parkinson’s Disease with and without REM Sleep Behavior Disorder over five years

S. Elasfar, H. Hameed, K. Ehgoetz-Martens (Waterloo, Canada)

Salivary and Plasma Heme Oxygenase-1 Concentration as a New Potential Biomarker in Parkinson Disease

R. Yadav (Kathmandu, Nepal)

Sex Differences for Regional Lewy Body Pathology in Pathologically-Defined Lewy Body Dementia

E. Bayram, D. Coughlin, S. Koga, I. Litvan, D. Dickson (La Jolla, USA)

String Vessel Formation Regionally Increases in Long Duration Parkinson’s Disease

D. Dik, GM. Halliday, V. Sytnyk, C. Shepherd (Randwick, Australia)

Study of the functional role of circulating extracellular vesicles as mediators of inflammation in cellular models of Parkinson`s disease

A. Yadav, E. Vacchi, S. Pinton, A. Kaelin-Lang, G. Melli (Bellinzona, Switzerland)

Understanding Sleep-wake Disturbances in Dementia with Lewy Bodies Using Parametric and Non-parametric Measures in Wrist Actigraphy

J. Anderson, N. Chiu, J. Pye, R. Grunstein, S. Lewis, E. Matar (Camperdown, Australia)